| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.90▲ | 1.90▲ | 1.91▲ | 1.92▲ | 1.84▲ |
| MA10 | 1.90▲ | 1.91▲ | 1.91▲ | 1.93▼ | 1.99▼ |
| MA20 | 1.90▲ | 1.90▲ | 1.89▲ | 1.85▲ | 2.23▼ |
| MA50 | 1.91▲ | 1.89▲ | 1.93▼ | 2.11▼ | 2.58▼ |
| MA100 | 1.90▲ | 1.92▼ | 1.92▼ | 2.23▼ | 2.86▼ |
| MA200 | 1.89▲ | 1.91▼ | 1.76▲ | 2.54▼ | 2.40▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | 0.000▼ | 0.005▲ | 0.023▲ | -0.033▼ |
| RSI | 54.143▲ | 53.168▲ | 51.537▲ | 50.287▲ | 43.907▼ |
| STOCH | 26.825 | 44.643 | 42.619 | 55.031 | 18.782▼ |
| WILL %R | -42.857 | -64.286 | -45.000 | -50.943 | -75.956▼ |
| CCI | 33.194 | -26.087 | 32.734 | 9.050 | -43.798 |
|
Wednesday, February 25, 2026 03:42 AM
Royalty revenues were $0.6 million, compared to $0.7 million in 2024. Total operating expenses were $49.6 million, essentially flat versus $49.3 million in 2024. Net loss was $45.9 million, or $0.69 ...
|
|
Tuesday, February 24, 2026 08:30 AM
Reported positive update from Phase 2 CRDF-004 trial in first-line RAS-mutated mCRC, with the 30 mg onvansertib + FOLFIRI/bev arm demonstrating: • Robust ORR of 72.2% (vs 43.2% with combined SoC of ...
|
|
Wednesday, February 18, 2026 11:00 PM
SAN DIEGO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/03/26 | 1.95 | 1.99 | 1.88 | 1.92 | 610,900 |
| 16/03/26 | 1.895 | 1.915 | 1.855 | 1.895 | 454,813 |
| 13/03/26 | 1.92 | 1.98 | 1.82 | 1.86 | 352,600 |
| 12/03/26 | 1.96 | 1.96 | 1.835 | 1.91 | 702,767 |
| 11/03/26 | 1.98 | 2.02 | 1.91 | 2.01 | 595,384 |
| 10/03/26 | 1.99 | 2.055 | 1.9542 | 2.02 | 547,281 |
| 09/03/26 | 1.80 | 2.01 | 1.79 | 1.99 | 1,043,694 |
| 06/03/26 | 1.85 | 1.93 | 1.82 | 1.88 | 422,782 |
| 05/03/26 | 1.98 | 1.98 | 1.81 | 1.87 | 548,700 |
| 04/03/26 | 1.90 | 2.01 | 1.87 | 1.98 | 706,628 |
|
|
||||
|
|
||||
|
|